查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
营养补充剂 CDMO 市场 - 增长、未来前景、竞争分析，2023-2031 年
市场调查报告书
商品编码
1313727

营养补充剂 CDMO 市场 - 增长、未来前景、竞争分析，2023-2031 年

Nutraceuticals CDMO Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

由于对定制营养补充剂以及製造和开发流程外包的需求不断增加，营养补充剂 CDMO（合同开发和製造组织）市场正在经历显着增长。 这一市场是专门的 CDMO 为营养保健品公司提供配方开发、製造、包装和其他相关服务的市场。 由于营养保健品行业的不断扩大以及对具有成本效益和高效的製造解决方案的需求，预计未来几年营养保健品 CDMO 市场收入将显着增长。 预计 2023 年至 2031 年期间，全球营养保健品 CDMO 市场将以 7.9% 的复合年增长率增长。 这种增长是由于消费者健康意识增强、人口老龄化以及慢性病患病率上升等因素造成的。 营养保健品公司越来越依赖 CDMO 来利用其专业知识、能力和基础设施来加速产品开发和简化製造流程。

定制营养补充剂的需求不断增加

营养补充剂市场对满足特定消费者需求的定制产品的需求正在激增。 这种动态是由多种因素推动的，包括消费者偏好的变化、对预防性保健的兴趣增加以及对营养补充剂潜在健康益处的认识提高。 如今的消费者正在寻找个性化和有针对性的解决方案，以解决他们独特的健康问题和目标。 这种定制需求为营养保健品公司提供定制产品创造了巨大的机会。 CDMO 在满足这种定制需求方面发挥着至关重要的作用。 凭藉配方开发方面的专业知识和对最新市场趋势的了解，CDMO 可以帮助营养保健品公司创造符合消费者偏好的创新产品。 CDMO 为优化产品功效和吸引力的成分选择、剂型和输送系统提供了宝贵的见解。 通过与 CDMO 合作，营养保健品公司可以开发与目标消费者产生共鸣的独特且差异化的产品。

製造和开发流程外包

营养保健品 CDMO 市场的一个显着驱动因素是营养保健品公司外包製造和开发流程的趋势不断增长。 这一驱动因素主要是出于简化运营、降低成本以及专注于营销、销售和产品创新等核心能力的愿望。 通过与 CDMO 合作，营养保健品公司可以利用 CDMO 的专业知识和基础设施来优化其製造流程。 CDMO拥有先进的设备、设施和技术专长，确保高效生产和高质量标准。 CDMO 提供端到端解决方案，包括配方开发、原材料采购、製造、包装和监管合规。 通过将製造和开发流程外包给 CDMO，营养保健品公司获得了灵活性和可扩展性。 适应不断变化的市场需求并有效管理生产波动，无需大量资本投资。 此外，CDMO 还可以通过规模经济、资源共享和供应链管理专业知识来提高成本效率。

监管合规性和质量保证

监管合规和质量保证是营养药品 CDMO 市场的关键驱动因素。 营养保健品行业须遵守严格的监管要求，以确保产品安全、功效并符合当地或国际标准。 遵守这些法规对于保护消费者的健康和维护膳食补充剂公司的声誉至关重要。 CDMO 在帮助营养保健品公司满足这些监管标准方面发挥着关键作用。 CDMO 对监管环境有深入的了解，可以指导公司满足复杂的要求。 CDMO 促进遵守良好生产规范 (GMP) 并进行质量保证测试，以确保产品符合所需的规格和标准。 通过与 CDMO 合作，营养保健品公司可以降低与监管不合规相关的风险。 CDMO 的质量控制、文件记录和监管提交专业知识确保产品的开发、製造和分销符合监管指南。 这是由于消费者安全担忧的增加、遵守不断变化的监管框架的需要以及不合规的潜在法律和财务后果所驱动的。

监管合规挑战

市场条件的潜在限制之一是复杂且不断变化的监管环境。 营养保健品行业须遵守监管机构的各种法规和指南，以确保产品的安全性、有效性和合规性。 满足这些监管要求对于膳食补充剂公司和 CDMO 来说都是一个挑战。 膳食补充剂受到严格的监管，以确保消费者安全和产品质量。 CDMO 必须遵守良好生产规范 (GMP)、标籤要求和产品标籤等法规。 遵守不同区域或国际法规的需要可能在一致性和效率方面构成挑战。 膳食补充剂的监管环境在不断发展。 可能会引入新的法规、指南和标籤要求，并且可能会修改现有法规。 CDMO 适应这些变化并确保合规性需要时间和资源，并且可能会影响运营和时间表。 膳食补充剂行业在不同地区和国家运营，每个地区和国家都有自己的监管框架。 服务于全球的 CDMO 必须满足许多监管要求，这些要求因市场而异。 遵守这些差异会增加复杂性并增加 CDMO 的负担。 虽然监管合规性挑战可能是营养药品 CDMO 市场的一个限制因素，但这些挑战为 CDMO 提供了一个机会，通过提供监管专业知识和确保客户合规性来脱颖而出。

药丸和胶囊：膳食补充剂输送的支柱

膳食补充剂 CDMO 市场按片剂/胶囊、粉末、软胶囊和其他剂型细分。 每种剂型都有其自身的特点和优点，可满足不同消费者的喜好和要求。 片剂和胶囊是膳食补充剂行业最常见的剂型。 这些剂型方便、剂量精确且易于摄入。 这些剂型因其熟悉且易于融入日常生活而深受消费者欢迎。 膳食补充剂 CDMO 市场以片剂和胶囊销售为主。 片剂和胶囊被广泛使用，并且由于消费者对传统固体剂型的偏好，预计其需求将持续增长。 其他类别包括营养药品 CDMO 市场中的各种创新新剂型，例如软糖、液体、喷雾剂和舌下製剂。 这些剂型提供独特的递送机制和消费者体验。 其他细分市场的特点是利基产品，预计在消费者对新颖、方便剂型的需求的推动下将出现显着增长。

製造和包装：引领膳食补充剂 CDMO 市场

製造和包装服务包括大规模膳食补充剂的製造和包装。 这包括混合、封装、压片、标籤和包装等过程。 这些服务对于确保高效且合规的製造运营至关重要。 由于对可靠、高质量製造能力的需求，製造和包装服务预计将占收入的很大一部分。 膳食补充剂 CDMO 市场的监管合规服务预计将出现相对较高的复合年增长率，因为它们在确保市场准入和消费者信心方面发挥着关键作用。 这些服务在确保膳食补充剂产品满足监管机构制定的严格要求和标准方面发挥着重要作用。 这些服务包括协调复杂的监管框架、获得所需的认证、进行审核、确保产品安全和合规性等等。 对膳食补充剂行业日益严格的监管审查，加上消费者安全和产品质量日益增长的担忧，正在推动对强大的监管合规服务的需求。 随着监管环境不断发展并变得更加严格，膳食补充剂公司开始求助于专门从事监管合规的 CDMO，以帮助他们有效应对这一复杂的环境。

北美：收入和市场占有率领先

北美在膳食补充剂 CDMO 市场中占据了很大的收入份额，这得益于其强大的市场影响力、先进的製造能力和明确的监管框架。 这一强劲的市场地位反映了消费者对营养补充剂和功能性食品的需求不断增长，原因包括对预防性保健的兴趣日益浓厚、健康意识不断增强以及健康意识生活方式的采用等。 亚太地区是市场上一个充满活力且高增长的地区，各种因素推动了膳食补充剂的需求。 该地区人口众多、可支配收入不断增加、生活方式不断变化以及中产阶级不断壮大，为营养补充剂创造了肥沃的市场环境。 中国、日本和印度等国家在推动亚太地区市场增长方面发挥着关键作用。 中国人口众多，为营养药品 CDMO 满足不断增长的消费者需求提供了巨大的机会。 该国不断壮大的中产阶级以及对健康和保健日益增长的兴趣正在推动对营养补充剂和功能性食品的需求激增。 同样，在老龄化社会和强调预防医学的文化的推动下，日本也建立了营养补充剂市场。 印度中产阶级不断扩大，健康意识不断增强，也对该地区的市场增长做出了重大贡献。

竞争格局

目录

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要产品
  • 市场细分
  • 调查方法
    • 第一阶段 - 二次调查
    • 第二阶段 - 初步调查
    • 第三阶段 - 专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

第三章膳食补充剂 CDMO 市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采取的策略
  • 主要产业战略
  • 层级分析：2022 年与 2031 年

第四章营养补充剂 CDMO 市场：宏观分析和市场动态

  • 简介
  • 2021-2031年全球营养补充剂CDMO市场价值
  • 市场动态
    • 市场驱动因素
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章营养补充剂 CDMO 市场：按剂型 2021-2031

  • 市场概览
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 药丸和胶囊
    • 粉末
    • 软凝胶
    • 其他

第 6 章营养补充剂 CDMO 市场：按服务分类 2021-2031

  • 市场概览
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 产品配方和开发
    • 製造和包装
    • 研究与开发 (R&D)
    • 监管合规性
    • 其他

第 7 章营养补充剂 CDMO 市场：按公司规模划分 2021-2031

  • 市场概览
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 中小企业
    • 中型企业
    • 大型公司

第8章2021-2031年北美营养补充剂CDMO市场

  • 市场概览
  • 营养药品 CDMO 市场：按剂型分类 2021-2031
  • 营养药品 CDMO 市场：按服务分类 2021-2031 年
  • 营养药品 CDMO 市场：按公司规模划分，2021-2031 年
  • 营养药品 CDMO 市场：按地区划分 2021-2031 年
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 9 章英国和欧盟膳食补充剂 CDMO 市场 2021-2031

  • 市场概览
  • 营养药品 CDMO 市场：按剂型分类 2021-2031
  • 膳食补充剂 CDMO 市场：按服务分类 2021-2031 年
  • 膳食补充剂 CDMO 市场：按公司规模划分，2021-2031 年
  • 膳食补充剂 CDMO 市场：按地区划分 2021-2031 年
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 10 章 2021-2031 年亚太营养药品 CDMO 市场

  • 市场概览
  • 膳食补充剂 CDMO 市场：按配方划分 2021-2031 年
  • 膳食补充剂 CDMO 市场：按服务分类 2021-2031 年
  • 膳食补充剂 CDMO 市场：按公司规模划分，2021-2031 年
  • 膳食补充剂 CDMO 市场：按地区划分 2021-2031 年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第 11 章 2021-2031 年拉丁美洲营养药品 CDMO 市场

  • 市场概览
  • 膳食补充剂 CDMO 市场：按配方划分 2021-2031 年
  • 膳食补充剂 CDMO 市场：按服务分类 2021-2031 年
  • 膳食补充剂 CDMO 市场：按公司规模划分，2021-2031 年
  • 膳食补充剂 CDMO 市场：按地区划分 2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第12章中东和非洲膳食补充剂 CDMO 市场 2021-2031

  • 市场概览
  • 膳食补充剂 CDMO 市场：按配方划分 2021-2031 年
  • 膳食补充剂 CDMO 市场：按服务分类 2021-2031 年
  • 营养药品 CDMO 市场：按公司规模划分，2021-2031 年
  • 营养药品 CDMO 市场：按地区划分 2021-2031 年
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲地区

第13章公司简介

  • Catalent Lonza Group
  • Royal DSM
  • BASF
  • Kerry Group
  • Archer Daniels Midland
  • Glanbia
  • Capsugel
  • Aenova Group
  • NutraScience Labs
  • Nutragenesis
  • Pharmavite
  • SirioPharma
  • Balchem Corporation
  • SirioPharma International
  • 其他主要企业
Product Code: 139651-07-23

The nutraceuticals CDMO (Contract Development and Manufacturing Organization) market is experiencing substantial growth due to increasing demand for customized nutraceutical products and the outsourcing of manufacturing and development processes. This market involves the provision of contract services by specialized CDMOs to nutraceutical companies for formulation development, manufacturing, packaging, and other related services. The market revenue for nutraceuticals CDMO is projected to grow significantly in the coming years, driven by the expanding nutraceutical industry and the need for cost-effective and efficient manufacturing solutions.The global nutraceuticals CDMO market is projected to grow at a CAGR of 7.9% during the forecast period of 2023 to 2031. This growth is attributed to factors such as the rising consumer awareness about health and wellness, the growing aging population, and the increasing prevalence of chronic diseases. Nutraceutical companies are increasingly relying on CDMOs to leverage their expertise, capabilities, and infrastructure to accelerate product development and streamline manufacturing processes.

Increasing Demand for Customized Nutraceutical Products

The nutraceuticals market is witnessing a surge in the demand for customized products that cater to specific consumer needs. This driver is propelled by several factors, including shifting consumer preferences, a growing focus on preventive healthcare, and the rising awareness of the potential health benefits offered by nutraceuticals. Consumers today seek personalized and targeted solutions that address their unique health concerns and goals. This demand for customization creates a significant opportunity for nutraceutical companies to offer tailored products. CDMOs play a pivotal role in meeting this demand for customization. With their expertise in formulation development and understanding of the latest market trends, CDMOs can help nutraceutical companies create innovative products that align with consumer preferences. They provide valuable insights into ingredient selection, dosage forms, and delivery systems that optimize the effectiveness and appeal of the products. By collaborating with CDMOs, nutraceutical companies can develop unique and differentiated offerings that resonate with their target consumers.

Outsourcing of Manufacturing and Development Processes

A prominent driver in the nutraceuticals CDMO market is the increasing trend of outsourcing manufacturing and development processes by nutraceutical companies. This driver is primarily motivated by the desire to streamline operations, reduce costs, and focus on core competencies such as marketing, sales, and product innovation. By partnering with CDMOs, nutraceutical companies can leverage their specialized capabilities and infrastructure to optimize manufacturing processes. CDMOs possess advanced equipment, facilities, and technical expertise to ensure efficient production and high-quality standards. They offer end-to-end solutions, including formulation development, ingredient sourcing, manufacturing, packaging, and regulatory compliance. Outsourcing manufacturing and development processes to CDMOs provides nutraceutical companies with flexibility and scalability. They can adapt to changing market demands and efficiently manage fluctuations in production volumes without incurring significant capital investments. Moreover, CDMOs can offer cost efficiencies through economies of scale, shared resources, and expertise in supply chain management.

Regulatory Compliance and Quality Assurance

Regulatory compliance and quality assurance are crucial drivers in the nutraceuticals CDMO market. The nutraceuticals industry is subject to stringent regulatory requirements to ensure product safety, efficacy, and compliance with regional or international standards. Compliance with these regulations is vital to protect consumer health and maintain the reputation of nutraceutical companies. CDMOs play a critical role in supporting nutraceutical companies in meeting these regulatory standards. They possess in-depth knowledge of the regulatory landscape and can guide companies through complex requirements. CDMOs facilitate adherence to Good Manufacturing Practices (GMP) and conduct quality assurance testing to ensure that products meet the necessary specifications and standards. By partnering with CDMOs, nutraceutical companies can mitigate the risks associated with regulatory non-compliance. CDMOs' expertise in quality control, documentation, and regulatory submissions ensures that products are developed, manufactured, and distributed in accordance with regulatory guidelines. This driver is driven by the increasing focus on consumer safety, the need to adhere to evolving regulatory frameworks, and the potential legal and financial consequences of non-compliance.

Regulatory Compliance Challenges

One of the potential restraints in the nutraceuticals CDMO market is the complex and ever-changing regulatory landscape. The nutraceutical industry is subject to various regulations and guidelines imposed by regulatory authorities to ensure product safety, efficacy, and compliance. Meeting these regulatory requirements can be challenging for both nutraceutical companies and CDMOs. Nutraceutical products are subject to rigorous regulatory scrutiny to ensure consumer safety and product quality. Compliance with regulations such as Good Manufacturing Practices (GMP), labeling requirements, and product claims can be demanding for CDMOs. The need to adhere to diverse regional or international regulations can pose challenges in terms of consistency and efficiency. The regulatory landscape for nutraceuticals is continuously evolving. New regulations, guidelines, and labeling requirements are introduced, and existing regulations may undergo revisions. Keeping up with these changes and ensuring compliance can be time-consuming and resource-intensive for CDMOs, potentially impacting their operations and timelines. The nutraceutical industry operates in different regions and countries, each with its own regulatory framework. CDMOs that offer services globally need to navigate through a multitude of regulatory requirements, which can differ significantly from one market to another. Adhering to these variations adds complexity and increases the burden on CDMOs. While regulatory compliance challenges can pose a restraint in the nutraceuticals CDMO market, it is important to note that these challenges can also present opportunities for CDMOs to differentiate themselves by providing regulatory expertise and ensuring compliance for their clients.

Tablets & Capsules: Pillars of Nutraceutical Delivery

The nutraceuticals CDMO market is segmented by dosage forms, including tablets & capsules, powder, softgel, and others. Each dosage form has its own characteristics and benefits, catering to different consumer preferences and requirements. Tablets and capsules are one of the most common dosage forms in the nutraceutical industry. They offer convenience, precise dosing, and ease of consumption. These dosage forms are popular among consumers due to their familiarity and ease of incorporating into daily routines. Tablets and capsules accounted for a significant revenue percentage in the nutraceuticals CDMO market. The demand for tablets and capsules is expected to continue due to their widespread use and consumer preference for traditional solid dosage forms. The others category includes various innovative and emerging dosage forms in the nutraceuticals CDMO market, such as gummies, liquids, sprays, and sublingual formulations. These dosage forms offer unique delivery mechanisms and consumer experiences. The others segment is characterized by niche products and is expected to witness notable growth, driven by consumer demand for novel and convenient dosage formats.

Manufacturing and Packaging: Leading the Nutraceuticals CDMO Market

Manufacturing and packaging services encompass the production and packaging of nutraceutical products at scale. This includes processes such as blending, encapsulation, tableting, labeling, and packaging. These services are crucial for ensuring efficient and compliant manufacturing operations. Manufacturing and packaging services are anticipated to hold a significant revenue percentage due to the demand for reliable and high-quality production capabilities. Regulatory compliance services in the nutraceuticals CDMO market are expected to witness a relatively high CAGR due to their critical role in ensuring market access and consumer trust. These services play a vital role in helping nutraceutical products meet the stringent requirements and standards set by regulatory authorities. They involve navigating complex regulatory frameworks, obtaining necessary certifications, conducting audits, and ensuring product safety and compliance. The increasing regulatory scrutiny on the nutraceutical industry, coupled with the rising focus on consumer safety and product quality, drives the demand for robust regulatory compliance services. As the regulatory landscape continues to evolve and become more stringent, nutraceutical companies rely on CDMOs specializing in regulatory compliance to navigate these complexities effectively.

North America: Leader in Revenue and Market Presence

North America holds a significant revenue share in the nutraceuticals CDMO market, driven by its robust market presence, advanced manufacturing capabilities, and well-defined regulatory framework. This strong market position can be attributed to the increasing consumer demand for dietary supplements and functional foods, driven by factors such as the growing focus on preventive healthcare, rising health consciousness, and the adoption of wellness-oriented lifestyles. Asia Pacific emerges as a dynamic and high-growth region in the nutraceuticals CDMO market, fueled by various factors that drive the demand for nutraceutical products. The region's large population base, rising disposable income, shifting lifestyles, and the growing middle class create a fertile market landscape for nutraceuticals. Countries like China, Japan, and India play a pivotal role in driving the market growth in the Asia Pacific region. With its massive population, China presents substantial opportunities for nutraceuticals CDMOs to cater to the increasing consumer demand. The rising middle class in the country, coupled with a growing focus on health and wellness, has led to a surge in demand for dietary supplements and functional foods. Similarly, Japan has a well-established nutraceutical market, driven by the aging population and the cultural emphasis on preventive healthcare. India, with its expanding middle class and rising health awareness, is also a key contributor to the region's market growth.

Competitive Landscape

The Nutraceuticals CDMO market features a competitive landscape with key players such as Catalent, Lonza Group, Royal DSM, BASF, Kerry Group, Archer Daniels Midland, Glanbia, Capsugel, Aenova Group, NutraScience Labs, Nutragenesis, Pharmavite, SirioPharma, Balchem Corporation, and SirioPharma International. These companies provide a wide range of services including formulation development, manufacturing, packaging, and quality control for nutraceutical products. The market's competitive trends are driven by factors such as innovation, technological advancements, geographic expansion, strategic partnerships, and acquisitions aimed at enhancing capabilities and expanding service offerings.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofNutraceuticals CDMO market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nutraceuticals CDMO market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Dosage Forms

  • Tablets & Capsules
  • Powder
  • Softgel
  • Others

Services

  • Product Formulation and Development
  • Manufacturing and Packaging
  • Research and Development (R&D)
  • Regulatory Compliance
  • Others

Company Size

  • Small Companies
  • Mid-Sized Companies
  • Large Companies

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Nutraceuticals CDMO market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Nutraceuticals CDMO market?
  • Which is the largest regional market for Nutraceuticals CDMO market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Nutraceuticals CDMO market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Nutraceuticals CDMO market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Nutraceuticals CDMO Market
  • 2.2. Global Nutraceuticals CDMO Market, By Dosage Forms, 2022 (US$ Million)
  • 2.3. Global Nutraceuticals CDMO Market, By Services, 2022 (US$ Million)
  • 2.4. Global Nutraceuticals CDMO Market, By Company Size, 2022 (US$ Million)
  • 2.5. Global Nutraceuticals CDMO Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Nutraceuticals CDMO Market: Competitive Analysis

  • 3.1. Market Positioning of Key Nutraceuticals CDMO Market Vendors
  • 3.2. Strategies Adopted by Nutraceuticals CDMO Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Nutraceuticals CDMO Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Nutraceuticals CDMO Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Tablets & Capsules
    • 5.3.2. Powder
    • 5.3.3. Softgel
    • 5.3.4. Others

6. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Product Formulation and Development
    • 6.3.2. Manufacturing and Packaging
    • 6.3.3. Research and Development (R&D)
    • 6.3.4. Regulatory Compliance
    • 6.3.5. Others

7. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Small Companies
    • 7.3.2. Mid-Sized Companies
    • 7.3.3. Large Companies

8. North America Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 8.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 8.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 8.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 8.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 8.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 8.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 8.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 8.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 8.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

9. UK and European Union Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 9.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 9.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 9.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

10. Asia Pacific Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 10.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 10.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 10.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

11. Latin America Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 11.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 11.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 11.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 11.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 11.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 11.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 11.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 11.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 11.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

12. Middle East and Africa Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 12.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 12.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 12.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 12.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 12.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 12.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 12.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 12.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 12.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Catalent, Lonza Group
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Royal DSM
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. BASF
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Kerry Group
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Archer Daniels Midland
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Glanbia
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Capsugel
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Aenova Group
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. NutraScience Labs
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Nutragenesis
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Pharmavite
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. SirioPharma
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Balchem Corporation
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. SirioPharma International
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. Other Notable Players
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 2 Global Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 3 Global Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 4 North America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 5 North America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 6 North America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 7 U.S. Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 8 U.S. Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 9 U.S. Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 10 Canada Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 11 Canada Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 12 Canada Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 19 UK Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 20 UK Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 21 UK Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 22 Germany Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 23 Germany Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 24 Germany Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 25 Spain Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 26 Spain Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 27 Spain Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 28 Italy Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 29 Italy Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 30 Italy Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 31 France Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 32 France Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 33 France Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 37 Asia Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 38 Asia Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 39 Asia Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 40 China Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 41 China Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 42 China Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 43 Japan Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 44 Japan Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 45 Japan Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 46 India Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 47 India Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 48 India Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 49 Australia Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 50 Australia Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 51 Australia Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 52 South Korea Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 53 South Korea Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 54 South Korea Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 55 Latin America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 56 Latin America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 57 Latin America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 58 Brazil Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 59 Brazil Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 60 Brazil Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 61 Mexico Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 62 Mexico Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 63 Mexico Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 70 GCC Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 71 GCC Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 72 GCC Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 73 Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 74 Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 75 Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Nutraceuticals CDMO Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Nutraceuticals CDMO Market: Quality Assurance
  • FIG. 5 Global Nutraceuticals CDMO Market, By Dosage Forms, 2022
  • FIG. 6 Global Nutraceuticals CDMO Market, By Services, 2022
  • FIG. 7 Global Nutraceuticals CDMO Market, By Company Size, 2022
  • FIG. 8 Global Nutraceuticals CDMO Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Nutraceuticals CDMO Market, 2022

FIG. 10Market Positioning of Key Nutraceuticals CDMO Market Players, 2022

FIG. 11Global Nutraceuticals CDMO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Nutraceuticals CDMO Market, By Dosage Forms, 2022 Vs 2031, %
  • FIG. 13 Global Nutraceuticals CDMO Market, By Services, 2022 Vs 2031, %
  • FIG. 14 Global Nutraceuticals CDMO Market, By Company Size, 2022 Vs 2031, %
  • FIG. 15 U.S. Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 22 France Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 24 China Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 26 India Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Nutraceuticals CDMO Market (US$ Million), 2021 - 2031